1. 'IC-labelled cyclamate has been administered to guinea pigs, rabbits, rats and humans. When given orally to these species on a cyclamate-free diet, cyclamate is excreted unchanged. In guinea pigs some 65 % of a single dose is excreted in the urine and 30 % in the faeces, the corresponding values for rats being 40 and 50 %, for man, 30-50 % and 40-60 %, and for rabbits, 90 and 5 %, the excretion being over a period of 2-3 days. 2. Cyclamate appears to be readily absorbed by rabbits but less readily by guinea pigs, rats and humans. 3. If these animals, including man, are placed on a diet containing cyclamate they develop the ability to convert orally administered cyclamate into cyclohexylamine and consequently into the metabolites of the latter. The extent to which this ability develops is variable, the development occurring more readily in rats than in rabbits or guinea pigs. In three human subjects, one developed the ability quite markedly in 10 days whereas two others did not in 30 days. Removal ofthe cyclamate from the diet caused a diminution in the ability to convert cyclamate into the amine. 4. In rats that had developed the ability to metabolize orally administered cyclamate, intraperitoneally injected cyclamate was not metabolized and was excreted unchanged in the urine. The biliary excretion of injected cyclamate in rats was very small, i.e. about 0.3 % of the dose. 5. The ability of animals to convert cyclamate into cyclohexylamine appears to depend upon a continuous intake of cyclamate and on some factor in the gastrointestinal tract, probably the gut flora.
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Cyclamic acid (cyclohexylsulphamic acid) as its sodium or calcium salt has been widely used as an artificial sweetening agent since 1959, when it was pronounced to be 'generally regarded as safe' (GRAS) by the Food and Drugs Administration (U.S.A.). It was, however, banned at the end of 1969 because it was suspected of being a bladder carcinogen in rats (Price et al., 1970) . It is a strong acid of pKa 1.9 and therefore would be expected to be excreted mainly unchanged when administered to animals (see Williams, 1959) . The earlier work on the metabolism of cyclamate (e.g. Taylor et al., 1951; Miller et al., 1966) seemed to confirm this view, but found cyclohexylamine in the urine of dogs and humans, but not in urine of rabbits, after oral doses of sodium cyclamate. This was supported by Leahy et al. (1967) , who found cyclohexylamine in the urine of a small proportion of a number of human volunteers who had taken sodium cyclamate orally. Subsequently several authors have reported the excretion of cyclohexylamine in the urine of man and animals receiving cyclamate orally.
The excretion of cyclohexylamine in the urine of cyclamate-pretreated rats has been reported, in some cases briefly, by Kojima & Ichibagase (1968) , Oser et al. (1968) , Sonders et al. (1969) , Dalderup et al. (1970) , Wallace et al. (1970) and Prosky & O'Dell (1971) and in the urine of humans on a cyclamate diet by Wills et aL (1968) , Davis et al. (1969) , Kojima Vol. 129 & Ichibagase (1969) , Asahina et al. (1971) and Litchfield & Swan (1971) . Kojima & Ichibagase (1968) have also shown that rabbits on daily oral doses of cyclamate excreted undefined amounts of cyclohexylamine, cyclohexanol and cyclohexanone.
The present work, which has in part been briefly reported (Renwick & Williams, 1969 (Drasar et al., 1972) . preceding paper) showed it to contain 0.6 % cyclohexylamine. The 114C]cyclamic acid (96mg; 910,uCi) in water (2ml) was passed through an ion-exchange column (10ml; Zeo-Karb 225 SRC 13; Na+ form) and eluted with water. The first 50ml of eluate contained 99 % of the 14C and paper chromatography showed it to contain no cyclohexylamine, whereas solvent extraction indicated no more than 0.02-0.03 % of cyclohexylamine. The solution of purified [14C]cyclamic acid was neutralized (pH7) with NaHCO3 and stored at -15°C. Freezedrying of the aqueous solution of free [14C]cyclamic acid resulted in the loss of 90% of the 14C, which was recovered in the 'cold finger' (at -70°C) of the apparatus. Freeze-drying of aqueous solutions of cyclamic acid was therefore carried out only after their adjustment to pH7. Other compounds were prepared as described in the preceding paper . Cyclohexylamine. (a) By g.l.c. Sodium chloride (0.2g/ml of the 24h urine, or a sample not exceeding 1 litre) was dissolved in the urine and the solution was adjusted to pH>11 with IOM-NaOH. The solution was extracted four times with 0.1 vol. of dichloromethane. Each extract was centrifuged for 15min at 2000rev./min and the aqueous phases, together with any emulsion which formed, were pooled for the next extraction. The extracts were passed through cotton-wool and then extracted twice with 0.2M-HCI (0.05vol. of original urine). The acid extract was cooled, adjusted to pH>11 with lOM-NaOH, saturated with NaCl and extracted with dichloromethane (2 x 5 ml). This extract was passed through a column (3 cm x 3 mm diam.) of anhydrous Na2SO4 and then diluted to lOml with dichloromethane. A sample (2,u) of this solution was analysed for cyclohexylamine by g.l.c. The instrument used was a Hewlett Packard Chromatograph (F. and M. Scientific 402 High Efficiency Gas Chromatograph) with a flame ionization detector and fitted with a 5ft (1.54m) glass column (3mm internal diam.) packed with polyethylene glycol 6000 (10%) and KOH (2%) on Chromosorb G (80-100 mesh). Cyclohexylamine had a retention time of 4.5 min under the conditions used, i.e.: column temp. 115°C; detector temp. 160°C; flash heater temp. 150°C; hydrogen pressure 201b/in2 (138kN-m2); air pressure 25 lb/in2 (172 kN m-2), nitrogen pressure 401b/in2 (276kN-m-2); flow rate 38ml/min. The detector response was linear between 0.5 and 25,ug of cyclohexylamine, and 0.1-0.5,tag could be detected but not accurately measured. If no cyclohexylamine was detected the whole urine extract was concentrated to 1 ml at 30°C under N2 and again subjected to g.l.c. The recovery of cyclohexylamine at 5mg/ litre of urine was 80-90% before the evaporation step and 60-70% after evaporation.
Materials and Methods

Chemicals
(b) By '4C counting. When [14C]cyclamate was administered cyclohexylamine was also determined by reverse isotope dilution as described in the preceding paper (Drasar et al., 1972) ].
To the neutral sample of urine or homogenate expected to contain [14C]cyclohexylamine was added an aq. 13.6% (w/v) non-radioactive cyclohexylamine hydrochloride soln. (0.5ml, i.e. 50mg of cyclohexylamine). The mixture was saturated with NaCI, 1972 treated with lOM-NaOH (1 ml) and then extracted by shaking for 30min with dichloromethane (lOml). The mixture was centrifuged to break any emulsion and the dichloromethane phase was separated and passed through cotton-wool. The extract was then shaken for 30min with 2M-HCI (5 ml) and the aqueous phase separated, brought to pH 12 with IOM-NaOH, saturated with NaCl and then extracted by shaking for 30min with dichloromethane (lOml). The organic phase was separated and filtered through cotton-wool. 'IC in a sample (1 ml) was determined by liquidscintillation counting and the extent of extraction of cyclohexylamine was measured by g.l.c. With the internal standard of cyclohexylamine, this method allowed a rapid and accurate determination of [14C]-cyclohexylamine, the recoveries being in the range t Expired air in day 1 was trapped and analysed for "'CO2 and ethanol-soluble volatile metabolites, both of which were negligible (0.03-0.07 % and <0.01 % respectively). Table 2 . Metabolites of cyclamate in normal and pretreated guinea pigs Animals, doses and pretreatment were as described in Table 1 . The urine and faeces were analysed by paper chromatography.
"'C in the first 24h excreta (% of dose) 
Results
Guinea-pig urine Table 1 shows the recovery of 14C in normal and cyclamate-pretreated guinea pigs. The recovery of 14C was satisfactory but it would appear that the elimination was slower in the pretreated guinea pigs than in normal animals. About one-third of the 14C was excreted in the faeces and the rest in the urine in 6-7 days. Table 2 shows the nature of the "4C in the urine excreted in 24h after dosing. In the normal animals the radioactivity was entirely in the form of cyclamate and no other product was detected. In the pretreated animals, although the main metabolite in the urine was cyclamate, the urine contained cyclohexylamine (0.3-2.5 % of the dose) and small amounts of other compounds. When chromatographed on paper these other compounds separated with RF 0.06 in solvent D (see the preceding paper: and appeared to be similar to the metabolites found after administration of [("C]-cyclohexylamine, i.e. mainly conjugates of transcyclohexane-1,2-diol . The 14C in the faeces of the pretreated animals was entirely in the form of cyclamate, except in one animal in which cyclohexylamine was found, but Table 3 shows the recovery of "4C in normal and cyclamate-pretreated rabbits. In both the 14C was excreted mainly in the urine, 91 % in 6 days in normal rabbits and 77% of the dose in 8 days in the pretreated animals. The faecal excretion in both was about 6-7%. The recovery of "4C was better in the normal animals (98 %) than in the pretreated (89%) and again it would appear that the elimination was a little slower in pretreated than in normal animals.
In Table 4 the nature of the 14C excreted in the urine in 24h after dosing is shown. In normal animals there may have been a slight metabolism of cyclamate, since 0.01-0.07 % of the dose of 14C appeared as cyclohexylamine and 0.7-0.9 % as other compounds. This unknown material had a lower RF value than cyclamate in all four solvents and was possibly an artifact similar to that reported previously by Miller et al. (1966) . In two of the pretreated animals there was an appreciable metabolism of cyclamate, but the third animal excreted the cyclamate almost entirely unchanged. Both cyclohexylamine (6.9 and 4.2% of the dose) and cyclohexyl glucuronide (8.2 and 6.2%) were detected in the urine of these two animals together with other metabolites (13.5 and 9.3 % of the dose), which were separated from cyclamate, cyclohexylamine and cyclohexyl glucuronide in solvent D with RF 0.59. Paper chromatography in all four solvents indicated that this material contained compounds similar to those excreted after the administration of [14C]cyclohexylamine . The unknown material found in the urine of normal rabbits given [14C]cyclamate was also detected in the urine of cyclamate-pretreated animals [0.8 % (0.4-1.3 %) of the dose in three rabbits].
The variability in the metabolism of cyclamate in individual pretreated rabbits is shown in Table 5 . After 3 months' pretreatment five out of six rabbits were producing detectable amounts of cyclohexylamine in quantities from 0.03 to 7.4 % of the dose of cyclamate, but one rabbit (no. 5), produced no detectable cyclohexylamine. On continuing the pretreatment for 5 months, the output of cyclohexylamine showed a tendency to increase.
Human urine
The recovery of 14C in three human subjects receiving ['4C]cyclamate orally is shown in Table 6 . On a cyclamate-free diet the recovery was 87-90% in 4-5 days after dosing. In two of the subjects (P.C.H. and A.G.R.) more "4C was recovered in the faeces (50 and 60 %) than in the urine (37 and 30 %), but the other subject (B.S.D.) excreted rather more in the urine (49%) than in the faeces (38 %). The three subjects were next given orally 3g of calcium cyclamate daily. After B.S.D. had been 17 days and the other subjects 30 days on this regime they were given orally 1 g of calcium cyclamate containing 8.8,uCi of 14C. In this experiment (see Table 6 ) the recovery of "4C in 4-5 days was 96-99% of the dose. In each case, the recovery of 14C in the urine was rather higher thail when the subjects were on a cyclamate-free diet, but the faecal excretion was the same as before the cyclamate diet. Table 7 shows the analysis ofthe urine samples from these three subjects for cyclohexylamine. One subject, B.S.D., excreted cyclohexylamine to the extent of 5 % of the dose of 4C before being put on a cyclamate diet, but after 17 days on a cyclamate diet the output of cyclohexylamine increased to nearly 8 % of the dose. The Table 5 . Cyclohexylamine excretion by rabbits pretreated with cyclamate Six rabbits were kept on a cyclamate-containing diet for 5 months. Each was then given an oral dose of calcium cyclamate (500mg/kg) and the cyclohexylamine in the next 24h urine sample was determined by g.l.c. None of the animals excreted cyclohexylamine (i.e. <0.01 %) when given a similar dose before pretreatment. The cyclohexylamine content of the calcium cyclamate administered was <0.0015 %.
Conversion into cyclohexylamine (% of dose) Table 9 . In the three groups of rats the recovery of 14C was satisfactory, being over 90%. In the normal rats more 14C was recovered in the faeces (52 %) than in the urine (39 %), but the reverse was true for both groups of pretreated rats. The nature of the "4C-containing compounds in the urine and faeces of the first 24h is shown in Table 10 . In the normal rats cyclamate was excreted entirely unchanged in the urine and faeces, but in the pretreated rats there was a considerable excretion of cyclohexylamine in both the urine and faeces, the urine containing much more than the faeces. There was a considerable individual variation in the amount of amine excreted. Thus rat no. 11 excreted 3.8 % of the dose (urine, 3.2 %; faeces, 0.6 %) as cyclohexylamine, whereas rat no. 45 excreted 47.8% (urine, 37.7%; faeces, 10.1 %). Table 10 also shows that in the pretreated rats other minor metabolites (up to 5 % of dose) were excreted in the urine but not in the faeces. The amounts of the other minor metabolites were proportional to the output of cyclohexylamine, being larger with the higher outputs of the amine. They were separated from cyclamate and cyclohexylamine in solvents A and D, in which they had RF values of 0.57 and 0.58 respectively. Since the RF values were similar to those for the metabolites of cyclohexylamine in rat urine, these minor metabolites are probably conjugates of 3-and 4-aminocyclohexanol .
The variability of the conversion of cyclamate into cyclohexylamine in 22 pretreated rats is illustrated in Table 11 . Four groups of five or six rats were pretreated with cyclamate for 3 months and the cyclohexylamine output of each of the rats was determined Table 10 . Excretion of metabolites of cyclamate in rats Rats, dosing and pretreatment were as described in Table 9 . The urine and faeces for the first 24h after dosing were analysed by paper chromatography.
14C excreted (% of dose) Cyclohexylamine in urine (% of dose) 2.6 (0.7-6.1) 5.0 (0.5-9.6) 13.2 (1.5-28.2) 16.6 (6.1-34.6) amine diminished with time. In 5 days the extent of conversion in rat no. 15 fell from 2.5 to 0.1 %, in rat no. 21 from 11.4 to 0.5 %, and in rat no. 32 from 25.0 to 0.7 % of the dose. 
Discussion
Absorption of cyclamate
Cyclamic acid is a fairly strong acid (pKa 1.9) and therefore it may not be readily absorbed. In the normal guinea pig, man and rat a significant amount of orally administered cyclamate is excreted unchanged in the faeces, that is about one-third in the guinea pig (Table 1) and about one-half in man (Table 6 ) and the rat (Table 9 ). In the rabbit, however, cyclamate seems to be readily absorbed, since some 90% of an oral dose is excreted in the urine (Table 3) . When these species are given a cyclamate-containing diet, it appears that those animals that become relatively good converters of cyclamate into cyclohexylamine also tend to excrete more of the 14C radioactivity in the urine. This is particularly true for the rat (Table  9) , which after pretreatment excretes 30-40 % in the faeces, compared with over 50 % before pretreatment. The guinea pig, which is a poor converter after pretreatment, excretes about the same amount in the faeces before and after pretreatment ( Table 1 ). The one human subject (B.S.D.) who became a good converter excreted more 14C in the urine after pretreatment (63 %) than before (49 %), but the two subjects who did not become converters showed lessmarked differences in the route of excretion before or after the cyclamate diet (Table 6 ). In the rabbit cyclamate pretreatment made little difference (Table  3) to the route of excretion and cyclamate was mainly excreted in the urine, whether it was metabolized or not. However, apart from the rabbit the observations in general suggest that if cyclamate undergoes metabolism then this metabolism occurs in the gastrointestinal tract, because the metabolite, cyclohexylamine, when given orally, is excreted mainly in the urine (see the preceding paper: Renwick ).
Since cyclamate is not readily absorbed from the gastrointestinal tract in the guinea pig, rat and man it can therefore reach the rectum, where, particularly in man, the main concentration of gut bacteria occurs.
Fate of cyclamate in normal animals
In normal guinea pigs (Table 2) , rabbits (Table 4 ) and rats (Table 10) , orally administered cyclamate is excreted entirely unchanged in the urine and faeces. This is its expected fate since it occurs as a highly polar anion at physiological pH values. In humans (Tables 7 and 8 ), one individual (B.S.D.) excreted cyclohexylamine in the urine with very small amounts in the first day (0.2%) but larger amounts in the second and third days after dosing (1.7 and 2.5 %). This delay is probably due to the time taken for the dose to reach the gut bacteria (Table 6 ) and to induce their cyclamate metabolism (see the next paper: Drasar et al., 1972) .
Fate ofcyclamate in cyclamate-pretreated animals Some animals maintained on a diet containing cyclamate develop the ability to convert cyclamate into cyclohexylamine, but the extent of this development appears to depend on the individual animal and to some extent on the species. Table 2 shows that three guinea pigs kept for 6 months on a cyclamate diet developed the ability to convert cyclamate into cyclohexylamine, but to a small extent. All six rabbits kept for 5 months on cyclamate (Table 5) developed the ability, but to varying degrees (0.01-7.2%). In three human males, one became a good converter in a few days whereas the other two became only very poor converters even after 30 days on a cyclamate diet (see Tables 7 and 8 ). The animals most readily trained to convert cyclamate into cyclohexylamine were rats, and Table 11 shows that 22 rats kept on a cyclamate diet for 3 months all became converters but to varying degrees. In this connexion it is important to remember that, of the four species 1972 studied, the rat has organisms all along the gastrointestinal tract from stomach to rectum whereas in man they are largely confined to the rectum and large intestine (see Drasar et al., 1970) .
Effect ofstopping cyclamate pretreatment When cyclamate was removed from the diet of rats that had become converters of cyclamate into cyclohexylamine while on the cyclamate diet, the ability of these animals to carry out the reaction diminished (Table 12) . This was also shown to be the case with the one human converter, B.S.D. (Table 8 injected into rats, it was almost entirely excreted unchanged in the urine. This experiment shows quite clearly that in cyclamate-pretreated rats the ability to form cyclohexylamine is associated with the gastrointestinal tract.
Our present results suggest that normal animals are unlikely to be able to metabolize cyclamate, but that they can be trained to do so by repeated ingestion of cyclamate. The main metabolite is then cyclohexylamine, which is itself further metabolized to a minor extent to the metabolites described in the preceding paper . The metabolism of cyclamate occurs in the gastrointestinal tract and, as is shown in the next paper (Drasar et al., 1972) , the gut flora are responsible for the conversion of cyclamate into cyclohexylamine but not for the further metabolism of this amine.
The main metabolite of cyclamate is cyclohexylamine, but once this is formed it is possible that small amounts of cyclohexanol, cyclohexanone, transcyclohexane-1,2-diol, the cis and trans isomers of 3-and 4-aminocyclohexanol and possibly N-cyclohexylhydroxylamine could be produced. The relationship ofthese metabolites to the suspected carcinogenicity of cyclamate is unknown at the present time, but it would appear that the continued ingestion of cyclamate could result in the production of increasing amounts of cyclohexylamine and consequently of the minor metabolites of cyclohexylamine.
